mechanisms by which volatile anesthetics induce general anesthesia. However, the exact mechanisms for different clinical actions of volatile anesthetics are still unclear. [1] [2] [3] With increasing concentrations of inhaled volatile anesthetics, their actions progress from amnesia (suppression of learning and memory), to hypnosis (unconsciousness) to immobility (no purposeful reactions to nociceptive stimulus). [3] [4] [5] [6] [7] Previous studies have demonstrated that different anesthetic end points of volatile anesthetics might result from their actions at different neural sites. 7, 8 For instance, it has been demonstrated that volatile anesthetics produce amnesia and hypnosis at the forebrain region, such as in the cortex and hippocampus, 7 whereas their immobilizing effects might result from effects on the spinal cord. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Meanwhile, many molecular targets and neural transmitters such as γ-aminobutyric acid type A, glycine, and glutamate receptors and potassium channels [1] [2] [3] 14 have been identified as contributing to individual anesthetic end point. [1] [2] [3] Hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels are mixed cationic ion channels activated by hyperpolarization. 15 Because of their unique electrophysiologic properties, HCN channels play a critical role as pacemakers in the heart and nervous system. 16, 17 Previous studies have shown that general anesthetics could produce BACKGROUND: Hyperpolarization-activated, cyclic nucleotide-gated (HCN) subtype 1 (HCN1) channels have been identified as targets of ketamine to produce hypnosis. Volatile anesthetics also inhibit HCN1 channels. However, the effects of HCN1 channels on volatile anesthetics in vivo are still elusive. This study uses global and conditional HCN1 knockout mice to evaluate how HCN1 channels affect the actions of volatile anesthetics. METHODS: Minimum alveolar concentrations (MACs) of isoflurane and sevoflurane that induced immobility (MAC of immobility) and/or hypnosis (MAC of hypnosis) were determined in wild-type mice, global HCN1 knockout (HCN1 −/− ) mice, HCN1 channel gene with 2 lox-P sites flanking a region of the fourth exon of HCN1 (HCN1 f/f ) mice, and forebrain-selective HCN1 knockout (HCN1 f/f : cre) mice. Immobility of mice was defined as no purposeful reactions to tail-clamping stimulus, and hypnosis was defined as loss of righting reflex. The amnestic effects of isoflurane and sevoflurane were evaluated by fear-potentiated startle in these 4 strains of mice. RESULTS: All MAC values were expressed as mean ± SEM. For MAC of immobility of isoflurane, no significant difference was found among wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice (all ~1.24%-1.29% isoflurane). For both HCN1 −/− and HCN1 f/f : cre mice, the MAC of hypnosis for isoflurane (each ~1.05% isoflurane) was significantly increased over their nonknockout controls: HCN1 −/− versus wild-type (0.86% ± 0.03%, P < 0.001) and HCN1 f/f : cre versus HCN1 f/f mice (0.84% ± 0.03%, P < 0.001); no significant difference was found between HCN1 −/− and HCN1 f/f : cre mice. For MAC of immobility of sevoflurane, no significant difference was found among wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice (all ~2.6%-2.7% sevoflurane). For both HCN1 −/− and HCN1 f/f : cre mice, the MAC of hypnosis for sevoflurane (each ~1.90% sevoflurane) was significantly increased over their nonknockout controls: HCN1 −/− versus wild-type (1.58% ± 0.05%, P < 0.001) and HCN1 f/f : cre versus HCN1 f/f mice (1.56% ± 0.05%, P < 0.001). No significant difference was found between HCN1 −/− and HCN1 f/f : cre mice. By fear-potentiated startle experiments, amnestic effects of isoflurane and sevoflurane were significantly attenuated in HCN1 −/− and HCN1 f/f : cre mice (both P < 0.002 versus wild-type or HCN1 f/f mice). No significant difference was found between HCN1 −/− and HCN1 f/f : cre mice. CONCLUSIONS: Forebrain HCN1 channels contribute to hypnotic and amnestic effects of volatile anesthetics, but HCN1 channels are not involved in the immobilizing actions of volatile anesthetics. (Anesth Analg 2015;121:661-6) HCN1 Channels Contribute to the Effects of Amnesia and Hypnosis but not Immobility of Volatile Anesthetics Cheng Zhou, PhD,* Peng Liang, MD, † Jin Liu, MD,* † Bowen Ke, PhD,* Xiaojia Wang, MD,* † Fengshan Li, MB,* Tao Li, PhD,* Douglas A. Bayliss, PhD, ‡ and Xiangdong Chen, PhD, MD* § www.anesthesia-analgesia.org aNeStheSia & aNalgeSia subtype-selective inhibition of HCN channels 18, 19 and that these channels contribute to general anesthetic actions. 20, 21 Among HCN channel subtypes (HCN1-4), the HCN1 subtype provides a plausible neuronal mechanism for enhancing cortical synchronization, which is a feature of hypnosis induced by general anesthetics. 22 In the previous study, the forebrain HCN1 channels were found to be a molecular substrate for the hypnotic action of ketamine. 21, 23 In addition, volatile anesthetics such as halothane, or the more commonly used isoflurane, are able to inhibit HCN1 channels. 18, 19 However, whether HCN1 channels contribute to the actions of volatile anesthetics in vivo is still unclear.
By using global and forebrain-selective HCN1 knockout (HCN1 f/f : cre) mice, we sought to evaluate the roles of HCN1 channels in mediating different end points of volatile anesthetics in vivo. Specifically, this study investigated the effects of HCN1 channels on the amnestic, hypnotic, and immobilizing actions of volatile anesthetics in vivo.
Animals
All protocols were approved by the Institutional Animal Experimental Ethics Committee of Sichuan University (Chengdu, Sichuan, China). The experiments were performed on 4 genotypes of male mice at age of 10 to 12 weeks, including wild-type C57BL/6J mice, global HCN1 knockout mice (HCN1 −/− ) mice, HCN1 channel gene with 2 lox-P sites flanking a region of the fourth exon of HCN1 (HCN1 f/f ), and HCN1 f/f : cre. Wild-type mice were used as nonknockout control of HCN1 −/− mice, and HCN1 f/f mice were used as nonknockout control for HCN1 f/f : cre mice. All these mice were housed in standard conditions, with a 12-hour light/dark cycle and with free access to food and water. HCN1 −/− mice were generated by a standard gene targeting and were bred as described previously. 18 HCN1 −/− mice displayed no gross physical or behavioral abnormalities. For HCN1 f/f : cre mice, a Cre-loxP strategy 24 was used to generate forebrain-selective deletion of HCN1 channels as described previously. 23 In brief, mice with floxed HCN1 gene (HCN1 f/f ) were crossed with animals in which Cre recombinase was expressed selectively in forebrain principal neurons under the control of the CaMKIIαpromoter, yielding littermates homozygous for floxed HCN1 alleles that were Cre positive (HCN1 f/f : cre mice).
Western Blot Analysis for HCN1 Expression
The cortex, hippocampus, cerebellum, and spinal cord tissues from 3 strains of mice (wild-type, HCN1 −/− , and HCN1 f/f : cre mice) were homogenized, and the protein concentrations of the supernatant were determined with a commercial BCA kit (Pierce, Rockford, IL). The supernatant (protein at 20 μg) was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. Primary antibodies of HCN1 (#ab65706, Abcam, Cambridge, MA) and β-actin (#ab1801, Abcam) were used. The membrane was incubated with horseradish peroxidase-conjugated anti-rabbit secondary antibody (1:10,000; Pierce) for 1 hour, and the blot was developed with a SuperSignal chemiluminescence detection kit (Pierce). A Kodak X-ray Processor 102 (Eastman Kodak, Rochester, NY) was applied for immunoblotting visualization and analyzed using the Quantity One software (Bio-Rad Laboratories, Hercules, CA).
Determination of Minimum Alveolar Concentrations in Mice
Immobility and hypnotic actions of volatile anesthetics were defined as no purposeful reactions to tail-clamping stimulus and loss of righting reflex (LORR), respectively. Minimum alveolar concentrations (MACs) of isoflurane and sevoflurane that induced immobility (MAC of immobility) and hypnosis (MAC of hypnosis) were determined in wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice. The mice were put into a transparent gas-tight plastic chamber (25 × 15 × 12 cm) to inhale isoflurane or sevoflurane, and a heating pad was placed under the chamber to maintain a rectal temperature of between 36°C and 38°C. The carrier gas flow (40% O 2 /60% N 2 ) was about 2 L/min. The CO 2 concentration of the chamber was maintained <5 mm Hg by adjusting carrier gas flow. Concentrations of isoflurane and sevoflurane (Abbott pharmacology Ltd. Co., Shanghai, China) were monitored in real time by the RGM monitor (Datex-Ohmeda, Louisville, CO).
MAC of isoflurane and sevoflurane were determined by up-and-down method as described previously. 25 In brief, MAC of isoflurane and/or sevoflurane was determined on 10 mice for each genotype. For each trial, 4 to 6 mice were randomly selected from each genotype and placed in the chamber. Two anesthetic end points were determined: Hypnosis of mice was defined as LORR, and immobility of mice was evaluated by tail-clamping stimulus (alligator clip, type 85, Newark Electronics, Dublin, CA). For isoflurane, initial concentrations of 0.44% and 0.72% were used, respectively, for determinations of hypnosis and immobility. Each concentration was kept for at least 20 minutes. Concentration of isoflurane was increased by 1.18-fold (e.g., 0.44%, 0.52%, 0.61%, 0.72%, 0.85%, and 1%) until successful end point (e.g., LORR) was observed. For each mouse, its MAC was the mid-concentration between successful end point and previous concentration. For each genotype, MAC was calculated as the average values for each mouse. For sevoflurane, initial concentrations of 1.04% and 1.45%, respectively, were used for determining hypnosis and immobility. Each concentration was kept for at least 30 minutes. Concentration of sevoflurane was also increased by 1.18-fold (e.g., 1.04%, 1.23%, 1.45%, 1.70%, and 2%) until successful end point (e.g., LORR) was observed. The experimenters were blinded to mice genotypes.
Experiment of Fear-Potentiated Startle
Amnesia induced by isoflurane and/or sevoflurane was evaluated by fear-potentiated startle system (Med Associates, Inc., St. Albans, VT). The protocol was modified from previous studies 26, 27 and was performed over 3 consecutive days. On the first day, startle responses were evoked by startle noise (105 dB for 50 milliseconds) and baseline startle was determined. Startle responses of mice were determined by an accelerometer, and average acceleration of mice was recorded. On the second day, these mice were trained to associate the conditioned noise (70 dB for 5 seconds) with a noxious shock stimulus on their foot (electrical shock, 0.4 mA for 100 milliseconds). The electrical shock was randomly applied for 5 to 10 seconds after conditioned noise, and the learning procedure was repeated for 9 times. During the learning procedure, isoflurane and/or sevoflurane were applied at the concentrations of 0.2-, 0.3-, and 0.4-fold MAC of immobility (as determined earlier). Concentrations of isoflurane and sevoflurane were monitored by the RGM monitor (Datex-Ohmeda). Air without volatile anesthetics was applied as control. On the third day, all mice were tested for fear-potentiated startle. No electrical shock was applied after the conditioned noise, and startle responses were evoked by startle noise. The sample size was 10 for each genotype.
Statistical Analysis
All the statistical analyses were performed by SPSS 16.0 for Windows (SPSS Inc., Chicago, IL). Because of the available mice number and estimated statistical power, sample size was 10 per group for behavioral investigations and 4 to 5 per group for Western blotting analysis. The MAC value was calculated as the average mid-value of each mouse and expressed as mean ± SEM. MAC values among different genotypes of mice (wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre) were compared by 1-way analysis of variance (ANOVA), and multiple comparisons among different genotypes were performed using post hoc tests (Bonferroni test for normal distribution and Games-Howell test otherwise). Fear-potentiated startles were calculated as the percentage of increased average acceleration (%) versus baseline. Fearpotentiated startles of mice were expressed as mean ± SEM and compared by 1-way ANOVA, and multiple comparisons among different genotypes of mice were performed using post hoc test (Bonferroni test). Significant threshold was defined as P < 0.05.
RESULTS

Western Blot Analysis Confirmed Global and Forebrain-Selective Deletion of HCN1
HCN1 channel subtype protein was detected in all the tissues, including cortex, hippocampus, cerebellum, and spinal cord in wild-type mice (Fig. 1 ). As expected for HCN1 −/− mice, HCN1 protein (about 100 kDa) was not detected in any of the tissues (Fig. 1) . For HCN1 f/f : cre mice, HCN1 protein was detected in the cerebellum and spinal cord but not in the cortex and hippocampus, confirming forebrainselective deletion of HCN1 channel subtype (Fig. 1 ). Table 1 . There was no significant difference in MAC of immobility of isoflurane among wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice (P = 0.972 by ANOVA). For isoflurane (Fig. 2 ), MAC of immobility was 1.25% ± 0.04%, 1.24% ± 0.04% (P > 0.9 versus wild-type), 1.29% ± 0.05% (P > 0.9 versus wild-type), and 1.26% ± 0.04% (P > 0.9 versus wild-type), respectively, for wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice. For sevoflurane ( Fig. 3 ), MAC of immobility was 2.62% ± 0.06%, 2.70% ± 0.06% (P > 0.9 versus wild-type), 2.66% ± 0.06% (P > 0.9 versus wild-type), and 2.63% ± 0.06% (P > 0.9 versus wild-type), respectively, for wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice.
MAC of Hypnosis Was
MAC of hypnosis was significantly increased in HCN1 −/− and HCN1 f/f : cre mice compared with controls. For isoflurane ( Fig. 2) , MAC of hypnosis was 0.86% ± 0.03%, 1.05% ± 0.03% (P < 0.001 versus wild-type), 0.84% ± 0.03% (P > 0.9 versus wild-type), and 1.04% ± 0.03% (P < 0.001 versus HCN1 f/f ), respectively, for wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice. For sevoflurane (Fig. 3 ), MAC of hypnosis was 1.58% ± 0.05%, 1.89% ± 0.05% (P < 0.001 versus wild-type), 1.56% ± 0.05% (P > 0.9 versus wild-type), and 1.90% ± 0.05% (P < 0.001 versus HCN1 f/f ), respectively, for wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice.
Amnestic Actions of Isoflurane and Sevoflurane
Were Attenuated in Both HCN1 − / − and HCN1 f/f : cre Mice
As shown in Figure 4 , baseline startle responses were similar among wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice. Fear-potentiated startle was also similar among these mice (no exposure to air flow, isoflurane, or sevoflurane). Fear-potentiated startles in air group were similar among wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice (Figs. 5 and 6). Both isoflurane and sevoflurane induced amnesia (suppression of learning and memory) in a concentrationdependent manner.
Fear-potentiated startles were significantly impaired by 0.4 MAC of isoflurane in wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice (P < 0.001 versus air group; Fig. 5 ). However, compared with their nonknockout controls, fear-potentiated startles were significantly increased in both HCN1 −/− (P < 0.001 versus wild-type) and HCN1 f/f : cre (P = 0.003 versus HCN1 f/f ) mice. No significant difference was found between HCN1 −/− and HCN1 f/f : cre mice (P = 0.197), indicating that forebrain HCN1 channels contributed to amnestic actions of isoflurane. For sevoflurane at 0.4 MAC of immobility (Fig. 6) , fear-potentiated startles were also significantly impaired in wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice (P < 0.001 versus air group). However, compared with their nonknockout controls, fear-potentiated startles were significantly increased in both HCN1 −/− (P < 0.001 versus wild-type) and HCN1 f/f : cre (P = 0.003 versus HCN1 f/f ) mice. No significant difference was found between HCN1 −/− and HCN1 f/f : cre mice (P = 0.740).
DISCUSSION
In previous studies, HCN1 channels were identified as an underlying molecular target of general anesthetics. Specifically, hypnotic actions of ketamine were significantly attenuated in both HCN1 −/− and HCN1 f/f : cre mice. 21, 23 In addition, volatile anesthetics such as isoflurane have been found to inhibit HCN1 channels. 18 These observations represent HCN1 channel as a molecular target for volatile anesthetics; however, the exact role of HCN1 channel in the actions of volatile anesthetics in vivo is unclear.
In this study, we demonstrated that HCN1 channels contributed to amnestic and hypnotic actions of isoflurane and sevoflurane. Because there was no significant difference between HCN1 −/− mice and HCN1 f/f :cre mice, the neural substrates of these effects likely include forebrain principle neurons. Interestingly, immobility actions of isoflurane and sevoflurane were unaffected by either global HCN1 channel knockout or forebrain-selective HCN1 channel deletion. This observation indicated that HCN1 channels do not contribute substantially to immobilizing actions of volatile anesthetics in vivo. This is not the first time HCN1 channels have been associated with learning and memory. [28] [29] [30] In previous studies, motor learning of mice was impaired by global HCN1 channel knockout, 28 but spatial learning was improved by forebrain-selective HCN1 channel deletion. 29 In addition, intracerebral injection of HCN blocker was found to impair some types of learning and memory. 31 For amnestic actions of volatile anesthetics in this study, a fear-potentiated startle paradigm was used because this behavioral assessment was amenable to administration of inhaled anesthetics. It has been demonstrated that many important brain regions are involved in fear-potentiated startle, such as amygdala and hippocampus. 32, 33 Previous studies have shown that spinal cord mediates most of the immobility action of volatile anesthetics. 4 HCN1 channels in the spinal cord were deleted in global, but not in HCN1 f/f : cre mice. If spinal HCN1 channels contribute to immobility actions of isoflurane and sevoflurane, MAC of immobility would be changed in HCN1 −/− mice but not in HCN1 f/f :cre mice. However, there was no difference in MAC of immobility among wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice, indicating that HCN1 channels might not be involved in the immobility action of volatile anesthetics in vivo. In this study, isoflurane and sevoflurane could still produce amnestic and hypnotic effects in HCN1 −/− and HCN1 f/f : cre mice, albeit at significantly higher concentrations. This finding indicates that some other molecular targets might also be involved in the actions of volatile anesthetics. Volatile anesthetics can modulate many other receptors and ion channels, such as γ-aminobutyric acid type A, glycine, and glutamate receptors and potassium channels, 1,2 and these may also contribute to these amnestic and hypnotic effects. In addition, the different roles of HCN1 channel in amnestic, hypnotic, and immobility actions of volatile anesthetics further confirmed the complexity of general anesthetic mechanisms. Therefore, it might be impossible to find an exclusive target for volatile anesthetics and multiple targets might be the most likely scenario. 3, 7 Some limitations in this study bear discussion. First, we tested only the effects of isoflurane and sevoflurane, and some other volatile anesthetics may be tested to further demonstrate the generalizability of our conclusions. Second, although we found that forebrain HCN1 channels contribute to the amnestic and hypnotic effects of isoflurane and sevoflurane, this is a relatively large brain region, and further refinement of the relevant neural substrate will require mice lines with even more restricted knockout, especially in the pyramidal neurons of hippocampus and cortex. Third, although the fear-potentiated startle experiment is a classical method for evaluating the amnestic actions of volatile anesthetics, [25] [26] [27] we did not quantitatively determine the activities of mice exposed to volatile anesthetics in amnesia evaluations. Thus, the hypnotic effect of volatile anesthetics might disturb the accuracy of amnesia evaluations. Of note, all the mice involved in amnestic evaluation remained conscious.
In summary, our study indicates that forebrain HCN1 channels contribute to hypnotic and amnestic actions of volatile anesthetics, whereas spinal HCN1 channels are not involved in the effect of immobility. E DISCLOSURES Name: Cheng Zhou, PhD. Contribution: This author helped design the study, conduct the study, analyze the data, and write the manuscript. Attestation: Cheng Zhou has seen the original study data, reviewed the analysis of the data, approved the final manuscript, and is the author responsible for archiving the study files. Name: Peng Liang, MD. Contribution: This author helped design the study, conduct the study, analyze the data, and write the manuscript. Attestation: Peng Liang has seen the original study data, reviewed the analysis of the data, approved the final manuscript, and is the author responsible for archiving the study files. Name: Jin Liu, MD. Contribution: This author helped design the study, analyze the data, and write the manuscript. Attestation: Jin Liu has seen the original study data, reviewed the analysis of the data, approved the final manuscript, and is the author responsible for archiving the study files. . Baseline startle responses of the 4 strains of mice were determined. A, Baseline startle responses were similar among wild-type, HCN1 −/− , HCN1 f/f , and HCN1 f/f : cre mice. The startle responses of mice were evoked by the startle noise. B, Fear-potentiated startle was determined after the conditional association between shock and conditioned noise and were also similar among these strains of mice. Values were expressed as mean ± SEM. HCN1 f/f : cre = forebrain-selective HCN1 channels knockout mice; HCN1 f/f = nonknockout control of HCN1 f/f : cre mice; HCN1 −/− = global HCN1 knockout mice. *P > 0.9. Figure 5 . Amnestic action of isoflurane determined by fear-potentiated startle. Amnestic action of isoflurane was enhanced in a concentrationdependent manner in all the strains of mice. The amnestic effect of isoflurane was significantly attenuated in both HCN1 −/− and HCN1 f/f : cre mice at 0.4 MAC. For isoflurane, the MAC used in this experiment was the MAC of immobility, which determined in this study. Potential values were expressed as mean ± SEM. HCN1 f/f : cre = forebrain-selective HCN1 channels knockout mice; HCN1 f/f = nonknockout control of HCN1 f/f : cre mice; HCN1 −/− = global HCN1 knockout mice; MAC = minimum alveolar concentration. *P < 0.05 versus wild-type mice; #P < 0.05 versus HCN1 f/f mice. Figure 6 . Amnestic action of sevoflurane determined by fear-potentiated startle. Amnestic action of sevoflurane was enhanced in a concentration-dependent manner in all the strains of mice. The amnestic effect of sevoflurane was attenuated in both HCN1 −/− and HCN1 f/f : cre mice at 0.2 to 0.4 MAC. For sevoflurane, the MAC used in this experiment was the MAC of immobility, which determined in this study. Potential values were expressed as mean ± SEM. HCN1 f/f : cre = forebrain-selective HCN1 channels knockout mice; HCN1 f/f = nonknockout control of HCN1 f/f : cre mice; HCN1 −/− = global HCN1 knockout mice; MAC = minimum alveolar concentration. *P < 0.05 versus wild-type mice; #P < 0.05 versus HCN1 f/f mice.
